Branch retinal vein occlusion: natural history of visual outcome.
暂无分享,去创建一个
[1] B. Doft,et al. Baseline characteristics and response to treatment of participants with hemiretinal compared with branch retinal or central retinal vein occlusion in the standard care vs corticosteroid for retinal vein occlusion (SCORE) study: SCORE study report 14. , 2012, Archives of ophthalmology.
[2] N. Bressler,et al. Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials. , 2012, Ophthalmology (Rochester, Minn.).
[3] S. Skalicky,et al. Glaucoma filtration surgery following sustained elevation of intraocular pressure secondary to intravitreal anti-VEGF injections. , 2012, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.
[4] P. Campochiaro,et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. , 2012, Ophthalmology.
[5] A. Di Giulio,et al. Drug safety evaluation of intravitreal triamcinolone acetonide , 2012, Expert opinion on drug safety.
[6] S. Hayreh,et al. HEMICENTRAL RETINAL VEIN OCCLUSION: Natural History of Visual Outcome , 2012, Retina.
[7] K. Nishida,et al. [Prognosis for branch retinal vein occlusion]. , 2011, Nippon Ganka Gakkai zasshi.
[8] Gary C. Brown,et al. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. , 2011, Ophthalmology.
[9] Fred Hendrikse,et al. A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS , 2011, Retina.
[10] F. Parmeggiani,et al. Systemic adverse drug reactions secondary to anti-VEGF intravitreal injection in patients with neovascular age-related macular degeneration. , 2011, Current vascular pharmacology.
[11] P. Campochiaro,et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. , 2011, Ophthalmology.
[12] Paul P. Lee,et al. Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration. , 2011, American journal of ophthalmology.
[13] M. Kahook,et al. Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents , 2010, British Journal of Ophthalmology.
[14] P. Mitchell,et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. , 2010, Ophthalmology.
[15] P. Campochiaro,et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[16] Sarah Gray,et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. , 2010, Ophthalmology.
[17] Ingrid U Scott,et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.
[18] S. Hayreh,et al. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. , 2008, Ophthalmology.
[19] M. Maia,et al. Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES) , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.
[20] S. Hayreh,et al. Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination. , 2005, Archives of ophthalmology.
[21] S. Hayreh. Prevalent misconceptions about acute retinal vascular occlusive disorders , 2005, Progress in Retinal and Eye Research.
[22] S. Hayreh,et al. Central retinal artery occlusion. Retinal survival time. , 2004, Experimental eye research.
[23] Sharon D. Solomon,et al. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. , 2004, Archives of ophthalmology.
[24] G. Coscas,et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. , 1994, American journal of ophthalmology.
[25] M. Zimmerman,et al. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. , 1994, American journal of ophthalmology.
[26] D. Finkelstein,et al. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. , 1992, Archives of ophthalmology.
[27] D. Finkelstein,et al. Argon laser photocoagulation for macular edema in branch vein occlusion. , 1986, Ophthalmology.
[28] J. Shilling,et al. Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. , 1984, The British journal of ophthalmology.
[29] R F Woolson,et al. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. , 1983, Ophthalmology.
[30] F. Gutman,et al. The natural course of temporal retinal branch vein occlusion. , 1974, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[31] Gass Jd,et al. The natural course of retinal branch vein obstruction. , 1974 .
[32] D. Clements,et al. Retinal vein occlusion. A comparative study of factors affecting the prognosis, including a therapeutic trial of Atromid S in this condition. , 1968, The British journal of ophthalmology.
[33] S. Hayreh,et al. Natural history of visual outcome in central retinal vein occlusion. , 2011, Ophthalmology.
[34] J. Gass,et al. THE NATURAL COURSE OF RETINAL BRANCH VEIN OBSTRUCTION , 1974, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[35] E. Kohner,et al. The visual prognosis in retinal branch vein occlusion. , 1973, Transactions of the ophthalmological societies of the United Kingdom.
[36] Clemett Rs,et al. The visual prognosis in retinal branch vein occlusion. , 1973 .
[37] J. Griffiths,et al. The prognosis in retinal vein thrombosis. , 1970, Transactions of the ophthalmological societies of the United Kingdom.
[38] Hill Dw,et al. The prognosis in retinal vein thrombosis. , 1970 .